Jury members in Montana have ordered the maker of the bone – strengthening drug, Zometa, to pay $3.2 million to a woman (Ms. Stevens) who has life long disabilities due to the drug. The ruling could affect many cases against Novartis Pharmaceuticals Corp. in the future. Currently, the pharmaceutical company has roughly 550 cases consolidated in a federal court as well as a state court. Ms. Stevens was awarded damages for income that will be lost due to the disability, pain, emotional distress, as well as the alterations to her normal lifestyle. The plaintiff now deals with lifelong complications while Novartis downplayed the effects and risks of the drug and did not give appropriate information concerning the drug, which has caused not only suffering to Ms. Stevens but also a severe public relations problem.
-Source: The Missoulian